Glycation and disease: a systematic review of the analytical methods and applications of advanced glycation end products (AGEs) as biomarkers of disease
- 10 April 2026
- journal article
- review article
- Published by Taylor & Francis in Critical Reviews in Clinical Laboratory Sciences
- Vol. 63 (7) , 621-649
Abstract
Over a century since Louis Camille Maillard first described the reaction that bears his name, advanced glycation end products (AGEs) resulting from the advanced stage of the glycation reaction have been widely implicated in the onset and progression of various non-communicable diseases. Although a number of studies on the relationship of AGEs with various diseases have been published, none of them to date has comprehensively and critically assessed the quantification of specific AGEs alongside a description of the analytical methods employed and their clinical relevance as biomarkers. We here provide a review of 116 pertinent articles from the last 10 years and describe the analytical methods, the matrices investigated, and the findings related to specific glycation biomarkers in relation to diagnosis or prognosis of disease-in particular diabetes and its complications, but also cardiovascular and renal diseases, as well as other conditions. Significant trends from the last decade are the diversification of applications beyond diabetes and its complications, an increasing number of innovative, noninvasive approaches to quantifying glycation biomarkers which seek to facilitate large-scale screening and early intervention, and the emergence of approaches combining several markers into a suite of analytes for assessment using Z-scores or machine learning algorithms.Keywords
Funding Information
- Vietnamese Ministry of Education and Training (2051-BGDĐT)
This publication has 206 references indexed in Scilit:
- Relationship between advanced glycation end‐products and advanced oxidation protein products in patients with type 2 diabetes with and without albuminuria: A cross‐sectional surveyHealth Science Reports, 2024
- Advanced Glycation End Products and Bone Metabolism in Patients with Chronic Kidney DiseaseJBMR Plus, 2023
- Greater Carboxy-Methyl-Lysine Is Associated With Increased Fracture Risk in Type 2 DiabetesJournal of Bone and Mineral Research, 2021
- Implications of Changing Z-Score Models for Coronary Artery Dimensions in Kawasaki DiseasePediatric Cardiology, 2021
- The association between glycated albumin, glycohemoglobin, and glycated albumin to glycohemoglobin ratio in diabetic retinopathy of prediabetesThe Kaohsiung Journal of Medical Sciences, 2019
- Studies of advanced glycation end products and oxidation biomarkers for type 2 diabetesBioFactors, 2018
- Oxidation products are increased in patients affected by non-segmental generalized vitiligoArchives of Dermatological Research, 2017
- Skin autofluorescence as a marker of cardiovascular risk in children with chronic kidney diseasePediatric Nephrology, 2012
- Early- and advanced non-enzymatic glycation in diabetic vascular complications: the search for therapeuticsAmino Acids, 2010
- The Amadori and Heyns Rearrangements: Landmarks in the History of Carbohydrate Chemistry or Unrecognized Synthetic Opportunities?2001